Dr. Jamila Benmoussa, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,779 | 188 | 61.6% |
| Travel and Lodging | $2,107 | 8 | 27.2% |
| Consulting Fee | $870.00 | 1 | 11.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic MiniMed, Inc. | $2,813 | 21 | $0 (2020) |
| Novo Nordisk Inc | $1,558 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $491.48 | 11 | $0 (2021) |
| Insulet Corporation | $420.24 | 32 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $313.46 | 10 | $0 (2020) |
| Amgen Inc. | $278.98 | 10 | $0 (2019) |
| Medtronic, Inc. | $278.64 | 3 | $0 (2024) |
| Lilly USA, LLC | $273.48 | 24 | $0 (2020) |
| DEXCOM, INC. | $200.40 | 6 | $0 (2021) |
| Tandem Diabetes Care, Inc. | $149.70 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $332.52 | 4 | Medtronic, Inc. ($154.09) |
| 2023 | $1,122 | 6 | Novo Nordisk Inc ($903.32) |
| 2022 | $83.47 | 1 | Insulet Corporation ($83.47) |
| 2021 | $184.64 | 4 | DEXCOM, INC. ($73.85) |
| 2020 | $913.43 | 37 | Novo Nordisk Inc ($208.02) |
| 2019 | $3,277 | 116 | Medtronic MiniMed, Inc. ($1,655) |
| 2018 | $602.39 | 20 | Janssen Pharmaceuticals, Inc ($134.79) |
| 2017 | $1,241 | 9 | Medtronic MiniMed, Inc. ($946.97) |
All Payment Transactions
197 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $122.88 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 08/07/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $34.14 | General |
| 05/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Diabetes | ||||||
| 01/26/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $154.09 | General |
| Category: Durable Pump | ||||||
| 11/16/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $870.00 | General |
| 08/08/2023 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $106.79 | General |
| Category: Endocrinology | ||||||
| 07/07/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $111.41 | General |
| Category: Durable Pump | ||||||
| 06/17/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 02/01/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Diabetes | ||||||
| 02/01/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: Diabetes | ||||||
| 07/15/2022 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $83.47 | General |
| Category: Insulin Pump | ||||||
| 10/01/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $62.49 | General |
| 09/15/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $73.85 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/31/2021 | Medtronic, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Durable Pump | ||||||
| 03/18/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | Cash or cash equivalent | $35.16 | General |
| Category: TEPEZZA | ||||||
| 11/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.75 | General |
| 09/09/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.83 | General |
| 08/28/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Diabetes | ||||||
| 08/27/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $4.64 | General |
| 08/25/2020 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $35.52 | General |
| Category: Insulin Pump | ||||||
| 08/20/2020 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $11.11 | General |
| 08/17/2020 | Dexcom, Inc. | DEXCOM G6 CGM SYSTEM (Device) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/11/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, TRIJARDY XR | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Diabetes | ||||||
| 07/14/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $2.01 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 334 | 716 | $148,432 | $54,401 |
| 2022 | 3 | 383 | 876 | $177,007 | $65,189 |
| 2021 | 3 | 418 | 986 | $184,854 | $71,018 |
| 2020 | 13 | 598 | 908 | $148,485 | $55,323 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 192 | 558 | $83,700 | $34,548 | 41.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 121 | 127 | $57,912 | $16,963 | 29.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 31 | $6,820 | $2,890 | 42.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 199 | 637 | $93,670 | $35,357 | 37.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 137 | 146 | $63,327 | $22,369 | 35.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 47 | 93 | $20,010 | $7,464 | 37.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 232 | 770 | $109,340 | $42,327 | 38.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 152 | 161 | $64,239 | $24,350 | 37.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 34 | 55 | $11,275 | $4,341 | 38.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 115 | 326 | $46,292 | $17,916 | 38.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 86 | 89 | $35,511 | $13,982 | 39.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 110 | 157 | $32,970 | $10,582 | 32.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 47 | 52 | $8,215 | $4,351 | 53.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $6,400 | $2,234 | 34.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 33 | 35 | $4,283 | $1,811 | 42.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 14 | 16 | $3,280 | $1,257 | 38.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 13 | 13 | $5,239 | $1,152 | 22.0% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 59 | 74 | $1,924 | $672.48 | 35.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 15 | $2,130 | $597.81 | 28.1% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 12 | 18 | $1,566 | $479.82 | 30.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 63 | 80 | $480.00 | $249.34 | 51.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 12 | 13 | $195.00 | $38.76 | 19.9% |
About Dr. Jamila Benmoussa, M.D
Dr. Jamila Benmoussa, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2013. The National Provider Identifier (NPI) number assigned to this provider is 1083054332.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jamila Benmoussa, M.D has received a total of $7,756 in payments from pharmaceutical and medical device companies, with $332.52 received in 2024. These payments were reported across 197 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,779).
As a Medicare-enrolled provider, Benmoussa has provided services to 1,733 Medicare beneficiaries, totaling 3,486 services with total Medicare billing of $245,931. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Albany, NY
- Active Since 07/01/2013
- Last Updated 05/07/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1083054332
Products in Payments
- Minimed 670G System (Device) $2,805
- Ozempic (Drug) $422.34
- Omnipod (Device) $420.24
- FARXIGA (Drug) $388.33
- INVOKANA (Drug) $272.00
- MINIMED 780G (Device) $265.50
- EVENITY (Biological) $160.59
- RECORLEV (Drug) $122.88
- Repatha (Biological) $118.39
- JARDIANCE (Drug) $107.07
- t:slim X2 Insulin Pump with Control-IQ (Device) $106.79
- THYROGEN (Drug) $99.79
- Korlym (Drug) $97.90
- DEXCOM CGM (Device) $86.38
- DEXCOM G6 TRANSMITTER (Device) $73.85
- BAQSIMI (Drug) $70.35
- AFREZZA (Drug) $69.60
- JANUVIA (Drug) $62.22
- Tresiba (Drug) $61.52
- HUMULIN (Drug) $59.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Albany
Anuj Malhotra, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $224,738
Dr. Erica Parrotta, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $111,723
William Raible, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $42,671
Dr. Olumayowa Abiodun, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $33,199
Dr. Alexandra Paul, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $15,462
Dr. Sridhar Musuku, M.d Frca, M.D FRCA
Student in an Organized Health Care Education/Training Program — Payments: $14,736